首页> 外文期刊>Nuclear Medicine Review >Comparison of peritumoral and subareolar injection of Tc 99m sulphur colloid and blue-dye for detection of the sentinel lymph node in breast cancer
【24h】

Comparison of peritumoral and subareolar injection of Tc 99m sulphur colloid and blue-dye for detection of the sentinel lymph node in breast cancer

机译:肿瘤周围和乳晕下注射Tc 99m硫胶体和蓝染料检测乳腺癌前哨淋巴结的比较

获取原文
           

摘要

BACKGROUND: The new trend in diagnosis of the lymph node is sentinel node biopsy. This method has become increasingly accepted as a minimally invasive alternative to routine axillary dissection. Although the results of numerous studies have shown that sentinel node biopsy can accurately determine the axillary nodal status, the identification rates and false-negative rates have been variable. The sentinel lymph node is defined as the first node in the lymphatic basin that receives the primary lymphatic flow. MATERIAL AND METHODS: Between September 1998 and August 2002 123 patients with primary operative breast cancer without clinical palpable axillary lymph nodes were enrolled in the study. There were two groups of patients according to sentinel node identification technique: 51 patients (Group I) received parenchymal, peritumoral injection of 1.0 ml of 16 MBq Tc 99m -radiolabelled sulphur colloid and single intradermal injection of blue-dye over the tumour. The next 72 patients (Group II) received intradermal, periareolar one-site injection of 0.5 ml of 16 MBq Tc 99m -radiolabelled sulphur colloid and blue-dye. RESULTS: Sentinel lymph node was found in 41 (80.4%) cases in Group I and in 67 (93.0%) cases in Group II (p = 0.028). The localisation of the axillary lymph node as a "hot spot" visualised by lymphoscintigraphy was successful in 39/51 (76.5%) cases in Group I and 67/72 (93.0%) in Group II, p = 0.004). In both groups the success of sentinel node identification in the axillary region by lymphoscintigraphy was connected with sentinel lymph node finding during surgery (Group I: p CONCLUSIONS: This study shows that intradermal, periareolar one-site injection of Tc 99m -radiolabelled sulphur colloid and bluedye is superior to peritumoral 4-sites injections Tc 99m -radiolabelled sulphur colloid and single intradermal injection of bluedye over the tumour in sentinel lymph node identification.
机译:背景:淋巴结诊断的新趋势是前哨淋巴结活检。这种方法已被越来越多地接受为常规腋窝清扫术的微创替代方法。尽管大量研究的结果表明,前哨淋巴结活检可以准确确定腋窝淋巴结的状态,但鉴别率和假阴性率却是可变的。前哨淋巴结被定义为接受主要淋巴流的淋巴盆中的第一个淋巴结。材料与方法:在1998年9月至2002年8月之间,本研究纳入了123例无临床腋窝淋巴结肿大的原发性手术乳腺癌患者。根据前哨淋巴结识别技术,有两组患者:51例患者(第一组)在肿瘤周围接受了1.0 ml的肿瘤组织周围注射1.0 ml的16 MBq Tc 99m放射状的硫胶体,并皮内注射了蓝色染料。接下来的72名患者(第II组)接受了0.5 ml的16 MBqq Tc 99m放射标记的硫胶体和蓝染料的皮内乳晕腔内单点注射。结果:在第一组中发现前哨淋巴结的情况为41(80.4%),在第二组中发现为前哨淋巴结的情况为67(93.0%)(p = 0.028)。 Ⅰ组的39/51(76.5%)病例和II组的67/72(93.0%)病例通过腋窝淋巴管造影术将腋窝淋巴结定位为“热点”是成功的,p = 0.004)。在两组中,通过淋巴闪烁显像术在腋窝区域成功识别前哨淋巴结与手术中发现前哨淋巴结有关(第一组:p结论:这项研究表明,皮内,乳晕周围一处注射Tc 99m-放射标记的硫胶体和在前哨淋巴结识别中,bluedye在肿瘤周围优于肿瘤周围4部位注射Tc 99m放射放射的硫胶体和一次皮内注射bluedye。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号